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Spinal muscular atrophy (SMA) is caused by a drastic reduction in the ubiquitously expressed 
SMN protein, which is critical for the correct assembly of the snRNP complexes required for RNA 
splicing. However, it is unclear why loss of SMN and altered snRNP assembly only seem to affect 
motor neurons. Reporting in this issue, Zhang et al. (2008) challenge prior assumptions about the 
housekeeping function of SMN and demonstrate that loss of SMN leads to highly tissue-specific 
effects on splicing.One of the major conundrums in neuro-
logical disease research is why mutations 
in genes that are widely expressed both 
inside and outside of the nervous system 
can lead to diseases characterized by 
degeneration of highly specific subpopu-
lations of neurons. In the case of many 
dominant diseases, such as spinocer-
ebellar ataxia and familial amyotrophic 
lateral sclerosis, it appears that neurons 
are selectively vulnerable to acquired 
protein toxicity conferred by specific 
amino acid changes. In contrast, reces-
sive diseases generally result from inac-
tivation or loss of function of a protein. In 
the neurological disease spinal muscular 
atrophy (SMA), the SMN (survival of motor 
neurons) gene is inactivated. The normal 
SMN protein is widely expressed in all tis-
sues and is considered to be part of the 
so-called “housekeeping” system of the 
cell. It has been widely assumed that such 
housekeeping functions are part of basal 
cellular activity and therefore are unlikely 
to be regulated in a tissue-specific and 572 Cell 133, May 16, 2008 ©2008 Elsevier Itime-dependent manner. In this issue of 
Cell, Zhang et al. (2008) provide some 
surprising new insights into the function 
of the SMN protein, which suggest that 
the general regulation of splicing through 
assembly of snRNPs may be more tis-
sue specific than previously appreciated. 
SMA is characterized by highly selective 
degeneration of motor neurons, leading 
to weakness and wasting of muscle and 
can be fatal. The restriction of pathology 
to one specialized kind of neuron is par-
ticularly surprising given the fact that SMN 
is expressed in every cell in the body and 
its complete absence is uniformly associ-
ated with cell death (Schrank et al., 1997). 
SMA is caused by mutations at the SMN 
locus, which result in the deletion of the 
SMN1 gene and variable residual copies 
of SMN2, a paralog that arose through an 
evolutionary duplication event. Due to a 
silent nucleotide change in exon 7 that 
abolishes an exonic splicing enhancer, 
SMN2 produces approximately 10% of 
the full-length functional SMN protein nc.compared with SMN1. SMA occurs at a 
critical threshold level of SMN when this 
protein is reduced by approximately 80%. 
This marked decrease in SMN affects 
motor neurons but is sufficient to ensure 
the normal function of all other cells (Lefe-
bvre et al., 1997).
SMN and its associated protein com-
plex is now known to have a central role 
in the integration of Sm core protein hep-
tamers with snRNAs into snRNP com-
plexes prior to importation of these com-
plexes into the nucleus to participate in 
the spliceosome (Kolb et al., 2007). Thus, 
reduction in SMN levels should lead to 
a generalized defect in splicing across a 
range of RNA transcripts. Could a defect 
in this basic function common to all cells 
really result in a phenotype that is spe-
cific to motor neurons?
Intriguingly, the SMN protein is also 
present in the axonal compartment of 
motor neurons and other nerve cells and 
is localized in granules that are actively 
transported into neuronal processes and 
figure 1. sMn Depletion and Motor neuron Loss
Motor neurons are among the longest cells in the body and consequently have special mechanisms for the delivery of proteins throughout the cell through 
transport along axons. RNA and associated protein complexes, including SMN and some of its protein partners, are present in the axon as well as the cell body. 
The severe reduction in SMN protein that causes the neurological disease spinal muscular atrophy (SMA) results in a defect in SMN-mediated snRNP assembly 
(integration of Sm proteins in the snRNP) with alterations in the levels of specific classes of snRNAs. However, in the neuronal axon, SMN may have a function 
distinct from snRNP assembly, and identification of such a function may be the key to understanding the pathophysiology of SMA. Alternatively, motor neurons 
could be preferentially vulnerable to defects in snRNP assembly and the downstream consequences for splicing.growth cones. Here, it is associated in a 
protein complex with Gemin2, Gemin3, 
and hnRNPR, but not with spliceosomal 
Sm proteins, suggesting that its func-
tion in the axon may be distinct from that 
in the neuronal cell body (Zhang et al., 
2006). One possibility for a neuron-spe-
cific, noncanonical function for axonal 
SMN is that it acts as a direct chaper-
one of RNP-mRNA complexes, modulat-
ing local protein translation at the distal 
ends of motor neurons during the forma-
tion and maintenance of neuromuscular 
junctions in development (Figure 1).
In their new study, Zhang and colleagues 
set out to understand what happens to 
splicing when SMN is reduced to levels 
approximating those seen in the tissues of 
SMA patients. Using a tetracycline-induc-
ible RNAi knockdown system in cultured 
human cancer (HeLa) cells, SMN levels 
were first reduced to 20% of wild-type levels, but no effect on snRNP assembly 
was observed. Further reduction of SMN 
to 5% of wild-type levels resulted in loss 
of snRNP assembly and decreased cell 
viability. This is consistent with data from 
humans and mice suggesting that there is 
excess capacity in snRNP assembly such 
that a reduction in SMN does not cause 
a phenotype until levels fall below about 
15%–20% of wild-type levels. Surprisingly, 
the authors observed that the reduction in 
snRNP assembly was associated with a 
differential reduction in snRNAs. In a neu-
ronal cell line, SMN reduction by 90% sim-
ilarly led to specific rather than generalized 
effects on snRNA levels. Notably, the U11 
snRNA was specifically reduced, confirm-
ing recent studies in mice (Gabanella et al., 
2007). Furthermore, in the neuronal cell 
line, the profile of the differential reduction 
in snRNAs was different from that seen in 
HeLa cells.CellWas this intriguing variability in the 
effect of SMN reduction physiologically 
relevant? The authors set out to inves-
tigate whether a similar consequence 
of SMN depletion could be observed in 
vivo using a mouse model of SMA, which 
recapitulates the main features of the 
human disease. As the phenotype of the 
SMA mice became progressively more 
severe, the authors observed a concor-
dant decrease in snRNP assembly activ-
ity in the brain, spinal cord, and kidney. 
As with in vitro experiments in the cell 
lines, comparing snRNA levels between 
different tissues revealed striking varia-
tions regarding which snRNA classes 
were affected.
If the reduction in SMN and the con-
sequent decrease in snRNP assembly 
have differential effects on snRNAs in dif-
ferent tissues, what are the downstream 
consequences for splicing? Using exon  133, May 16, 2008 ©2008 Elsevier Inc. 573
microarrays, the investigators found 
remarkable tissue-specific alterations in 
splicing and in the production of aberrant 
splice products between brain, spinal 
cord, and kidney in SMA mice. It is not 
clear at what stage of disease these mice 
were studied, and it is possible that some 
of the splicing changes might be second-
ary to the pathological process of motor 
neuron degeneration itself. However, 
this study does provide evidence that 
the well-characterized function of SMN 
in snRNP biogenesis may not be sim-
ply a background activity common to all 
cells. Instead, it may be a highly regulated 
process that when perturbed produces 
distinct detrimental effects in the spinal 
cord, the tissue that degenerates in SMA. 574 Cell 133, May 16, 2008 ©2008 Elsevier I
Protein translocation across membrane 
barriers is a fundamental process in all 
cellular organisms and a key component 
to host-pathogen interactions. Multiple 
structural analyses and genetic and bio-
chemical studies have led to the discov-
ery of several protein-conducting chan-
nels that utilize a variety of mechanisms 
(pushing, pulling, and ratcheting) for pro-
tein translocation. In general, the post-
translational translocation of folded pro-
teins is conducted by β-barrel channels in 
the bacterial outer membrane or nuclear 
pores comprised of α-helical transmem-
brane segments, whereas β-barrel chan-
nels of the mitochondrial outer membrane 
Twin Ushers Gu
Outer Membran
Robert Daniels1,2 and Staffan Normark1,2
1Swedish Institute for Infectious Disease Contr
2Department of Microbiology, Tumor and Cell B
*Correspondence: staffan.normark@smi.ki.se
DOI 10.1016/j.cell.2008.04.032
The chaperone/usher pathway is
gram-negative pathogenic bacte
of the PapC usher translocation d
tion intermediate. These new struIt remains to be resolved why significant 
aberrations detected in splicing in other 
tissues, such as kidney, do not produce 
a phenotype. If aberrant splicing is a sig-
nificant factor in the motor neuron degen-
eration seen in SMA, the challenge now 
is to understand precisely how this leads 
to cell death. This will involve a detailed 
assessment of the complex expression 
patterns of different transcripts and also 
a specific focus on motor neurons, as 
the spinal cord contains many cells not 
affected in SMA. Although it is clear that 
SMN deficiency affects motor neurons 
in a distinct way, there remains much to 
learn about the mechanistic details of cell 
death in this most catastrophic of neuro-
logical diseases.nc.
translocate proteins in an unfolded state. 
In contrast, the cotranslational transloca-
tion of bacterial and eukaryotic secre-
tory proteins occurs across homologous 
α-helical channels (Sec) in the bacte-
rial inner membrane or the endoplasmic 
reticulum (ER). Although many advances 
have been made toward understand-
ing protein translocation across different 
membranes, further progress in the field 
is hindered by the absence of high-reso-
lution structures that definitively portray a 
translocase in action.
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pathway) pili of pathogenic E. coli are 
transported across the bacterial outer 
membrane by a translocon termed the 
“usher.” Using crystal structure analysis 
of the usher combined with single par-
ticle cryo-electron microscopy of the 
usher containing a translocation inter-
mediate in lipids, the authors provide 
the first view of a translocase bound 
to a secretion intermediate at astound-
ing resolution. The PapC usher forms 
a large 24 strand β-barrel channel with 
inner dimensions of 45 Å by 25 Å that 
is sufficient for the translocation of the 
folded pili subunits PapA/K/E/F/G or 
he Bacterial 
, Sweden
 adhesive pili on the surface of 
08) present the crystal structure 
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